Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07116434) titled 'Discovery Diabetes' on Aug. 6.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Supportive Care. Masking: None (Open Label).

Primary Sponsor: Vanderbilt University Medical Center

Condition: Type 1 Diabetes

Intervention: Behavioral: Discovery Prgoram

Recruitment Status: Not recruiting

Phase: N/A

Date of First Enrollment: September 2025

Target Sample Size: 150

Countries of Recruitment: United States

To know more, visit https://clinicaltrials.gov/ct2/show/NCT07116434

Published by HT Digital Content Services with permission from He...